SHP Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$179K Hold
1,144
– – 0.01% 319
2026
Q2
$179K Sell
1,144
-56
-5% -$8.4K 0.01% 319
2026
Q1
$183K Sell
1,200
-289
-19% -$44.3K 0.01% 284
2025
Q4
$205K Hold
1,489
– – 0.02% 248

Other funds holding NVS

SHP Wealth Management's NVS Position: Q3 2026 in Review

SHP Wealth Management held its Novartis (NVS) position steady in Q3 2026 at 1,144 shares worth $179K. The position accounts for 0.01% of the portfolio, ranked #319.

SHP Wealth Management first reported a position in NVS in Q4 2025 and has held it in 4 quarters since. The position peaked at $205K in Q4 2025. 1,560 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • SHP Wealth Management held 1,144 shares of Novartis worth $179K as of Q3 2026.
  • SHP Wealth Management left its Novartis share count unchanged in Q3 2026.
  • Novartis made up 0.01% of SHP Wealth Management's portfolio in Q3 2026, its #319 holding.
  • SHP Wealth Management first reported a position in Novartis in Q4 2025 and has held it in 4 quarters since.
  • SHP Wealth Management's Novartis position peaked at $205K in Q4 2025.
  • 1,560 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on SHP Wealth Management's 13F filing for Q3 2026, filed 19 Nov 2026.